Coronary artery revascularization combined with server ischemic mitral valve repair early and midterm outcome

Authors

  • Okba F Ahmed Mosul Cardiac Center, Nineveh, Iraq Author
  • RabeaSalim Abduljabbar Al-Jumhoori Teaching Hospital, Nineveh Health Directorate, Ministry of Health and Environment, Nineveh, Iraq Author

DOI:

https://doi.org/10.61841/dyh69g28

Keywords:

mitral regurgitation, peripheral vascular disease, coronary angiography, Carotid Doppler study, coronary artery revascularization

Abstract

 Functional ischemic mitral regurgitation (MR) occur in up to 40% of patients after myocardial infraction. Chronic ischemic mitral regurgitation (IMR) is a frequent and important complication after myocardial infarction. This is a single center, retrospective, single cohort study, during two year period (2018–2020). It included all the cases of combined operation of MV repair and CABG. Follow-up of patients was performed through clinical visit.The patients were followed up for a median duration of (six months to 1 year).All patients underwent transthoracic echocardiography (TTE) and preoperative coronary angiography. Carotid Doppler study was requested for those patients with previous stroke and/or peripheral vascular disease (PVD).The followings were obtained; socio-demographic data, information regarding clinical courses, intraoperative findings, and post-operative follow up data.The study included 68 cases, the mean age was 58 years (ranging from 45 to 78 years), 36 (52.9%) were males and 32(47%) were female. The most common comorbidity was hypertension which was found in 22(32.3%) patients. The mean preoperative ejection fraction was 54%. Twenty-two patients had single graft, 29 patients underwent 3-vessel grafting, 17 patients had 2- vessel grafting.The CPB duration ranged from 120 to 140 min with a mean of 120 min and cross-clamp time ranged from 40 to 80 min. The average duration of admission to the intensive care unit was ranging from 48 h to 72 h. The patients stayed at hospital a mean of 8 days (ranging from 7 to 10 days). The most common complication was Arrhythmia which occurred in 8 cases and managed (Table 2). Overall mortality was 4.4% (3 patients), the   causes were as the followings; CVA in one case, multi-organ failure in one case and cardiac tamponade in one case who was presented two weeks after operation. In conclusion, early mortality was less, quality of life better, but no reduction in late mortality. 

Downloads

Download data is not yet available.

References

1. Aronson D, Goldsher N, Zukermann R, Kapeliovich M. Ischemic MR and risk of heart failure

after myocardial infarction. Arch Intern Med. 2006; 166:2362–2368

2. Piérard LA, Carabello BA. Ischaemic mitral regurgitation: pathophysiology, outcomes and the

conundrum of treatment. Eur Heart J. 2010;31:2996–3005

3. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al.

Guidelines on the management of valvular heart disease (version 2012).Eur Heart J.

2012;33:2451–96.

4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, et al. 2014

AHA/ACC guideline for the management of patients with valvular heart disease: a report of the

American College of Cardiology/ American Heart Association Task Force on Practice

Guidelines. J Am CollCardiol. 2014;63:e57– e185

5. Vahanian A, Alfieri O, Andreotti F, et al. The Joint Task Force on the Management of Valvular

Heart Disease of the European Society of Cardiology and the European Association for

CardioThoracic Surgery. Guidelines on the management of valvular heart disease (version

2012). Eur Heart J. 2012;33:2451– 96.

6. Fattouch et al, Efficacy of adding mitral valve restrictive annuloplasty to coronary artery

bypass grafting in patients with moderate ischemic mitral valve regurgitation: A randomized

trial, The Journal of Thoracic and Cardiovascular Surgery c August 2009.

7. Karimi A et al. EARLY OUTCOME OF CONCURRENT MITRAL VALVE

REPLACEMENT AND CORONARY ARTERY BYPASS GRAFTING, ActaMedicaIranica,

46(3): 213-217; 2008.

8. Adult cardiac surgery database. Society of Thoracic Surgeons, Chicago. 2012.

http://www.sts.org/national-database. Accessed 17 Dec 2015

9. M.P.B.O. Sá et al, Mitral valve replacement combined with coronary artery bypass graft

surgery in patients. Portuguese journal of cardiology,2013:32(2)131- 137

10. Wang et al, Repair or replace ischemic mitral regurgitation during coronary artery bypass

grafting? A meta-analysis, Journal of Cardiothoracic Surgery (2016) 11:141 DOI

10.1186/s13019-016-0536-6

11. Despotis GJ, Filos KS, Zoys TN, Hogue CW Jr, Spitznagel E, Lappas DG. Factors associated

with excessive postoperative blood loss and hemostatic transfusionrequirements: a multivariate

analysis in cardiac surgical patients. AnesthAnalg. 1996;82:13-21.

12. Sablotzki A, Welters I, Lehmann N, Menges T, Gorlach G, Dehne M, et al. Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-b in patients

undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 1997;11:763-8.

13. Taylor KM. Brain damage during cardiopulmonary bypass. Ann Thorac Surg. 1998;65:S20-6.

14. Acker MA, Parides MK, Perrault LP, et al. Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. N Engl J Med.2014; 370:23–32

15. Ahmed, O.F., Kakamad, F.H., Almudhaffar, S.S., Hachim, R.H., Najar, K.A., Salih, A.M., Hussen, D.A., Mohammed, S.H., Mustafa, M.Q., Mohammed, K.K. and Omar, D.A., 2021. Combined operation for coronary artery bypass grafting and mitral valve replacement; risk and outcome. International Journal of Surgery Open, 35, p.100393.

Downloads

Published

28.02.2022

How to Cite

F Ahmed, O., & Abduljabbar, R. (2022). Coronary artery revascularization combined with server ischemic mitral valve repair early and midterm outcome. International Journal of Psychosocial Rehabilitation, 26(1), 192-198. https://doi.org/10.61841/dyh69g28